Medigra - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 405,406 | 408,147 | 410,163 | 614,620 | 587,791 | 617,745 | 537,283 | 408,107 |
| Profit before tax | 81,298 | 31,299 | 80,024 | 57,656 | 58,220 | 54,267 | 70,564 | -6,889 |
| Net profit | 69,032 | 26,604 | 68,016 | 49,007 | 49,475 | 46,121 | 59,970 | -6,889 |
| Equity | 320,964 | 347,568 | 415,584 | 405,767 | 455,242 | 451,363 | 511,333 | 504,444 |
| Liabilities | 47,058 | 55,612 | 106,767 | 93,465 | 100,811 | 48,681 | 48,934 | 34,244 |
| Non-current assets | 111,864 | 132,914 | 315,395 | 284,414 | 308,839 | 224,318 | 175,213 | 146,750 |
| Current assets | 255,417 | 269,590 | 301,477 | 289,522 | 300,946 | 309,429 | 398,889 | 389,495 |
| Total assets | 367,281 | 402,504 | 616,872 | 573,936 | 609,785 | 533,747 | 574,102 | 536,245 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 116,052 | 85,706 | 75,536 |
| Social insurance contributions | - | - | - | - | - | 24,368 | 25,405 | 27,316 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +23.5% | +0.7% | +0.5% | +49.8% | -4.4% | +5.1% | -13.0% | -24.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.8% | 6.6% | 11.0% | 8.5% | 8.1% | 8.6% | 10.4% | -1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 21.5% | 7.7% | 16.4% | 12.1% | 10.9% | 10.2% | 11.7% | -1.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.0% | 6.5% | 16.6% | 8.0% | 8.4% | 7.5% | 11.2% | -1.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 20.1% | 7.7% | 19.5% | 9.4% | 9.9% | 8.8% | 13.1% | -1.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 55,283 | 55,657 | 55,303 | 85,761 | 81,075 | 90,402 | 77,679 | 56,291 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medigra - Social security debts
The company had no debts to Sodra
Medigra - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-28 | 2025-11-30 | 1.23 |
| 2024-12-06 | 2024-12-06 | 5.27 |
| 2024-12-05 | 2024-12-05 | 1146.16 |
| 2024-12-04 | 2024-12-04 | 1145.85 |
| 2024-12-03 | 2024-12-03 | 1141.2 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medigra, UAB (code 155310818) is a Private Limited Liability Company engaged in support services to forestry. In 2025, the company generated revenue of €408.1K, down from €537.3K in 2024 and €617.7K in 2023, showing a clear two-year decline in turnover. Net profit also weakened materially: after €46.1K in 2023 and €60.0K in 2024, the company reported a net loss of €6.9K in 2025, with a profit margin of -1.7%. The latest year’s return metrics were negative, with ROE at -1.4% and ROA at -1.3%, reflecting the loss-making result. The balance sheet remained conservative, with equity of €504.4K, liabilities of €34.2K and total assets of €536.2K in 2025. The equity ratio was 94.1% and debt-to-equity 0.07, indicating low leverage. Asset turnover stood at 0.76x. Revenue per employee was €58.3K, while profit per employee was -€984, consistent with the weaker 2025 performance.